Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 24, 2014
83 Pages - SKU: BMI5332216
Countries covered: Zimbabwe

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Zimbabwe's poor economic outlook, in addition to the government announcing budget cuts tohealthcare, means that we do not expect any meaningful interest from pharmaceutical companies in themedium-to-long term. The already dire situation, in which the health service is heavily reliant on donations,lacks skilled workers and essential medicines, and the fact that the vast majority of the healthcare budget isnot even disbursed, leads us to hold a very bleak outlook for the healthcare market in the country.

Headline Expenditure Projections

Pharmaceuticals: USD233mn in 2013 to USD251mn in 2014; +7.5% in US dollar terms. Forecastremains in line with last quarter's projections.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Zimbabwe Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Zimbabwe Q3 2014 by Business Monitor International
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2014BMI View: Zimbabwe's pharmaceutical industry suffers significantly from the country's frail economy andongoing political instability, with neither expected to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!